Dermata Therapeutics (NASDAQ: DRMA) — Perfil da empresa, notícias e dados financeiros
Dermata Therapeutics develops innovative dermatological treatments, addressing unmet needs for skin conditions.
Dermata Therapeutics
Dermata Therapeutics (NASDAQ:DRMA) is a dynamic health entity dedicated to developing innovative treatments across a broad spectrum of dermatological conditions. They focus on addressing unmet medical needs for patients struggling with acne, rosacea, and other skin-related ailments. Dermata Therapeutics is determined to push the boundaries of skincare by investing in research and development projects that pave the way for breakthrough treatments. Their objective remains clear: to revolutionize dermatological care and enhance patient well-being through effective, accessible, and novel therapeutic options.
Resumo
Operações
Produtos e/ou serviços de Dermata Therapeutics
- Development of innovative therapies targeting dermatological conditions like acne, rosacea, and psoriasis.
- Research on cutting-edge biologic treatments for severe skin diseases.
- Formulation of advanced skincare products leveraging proprietary drug delivery technologies.
- Collaboration with other biotech firms to co-develop dermatological solutions.
- Engagement in clinical trials to validate the efficacy and safety of new dermatologic treatments.
- Provision of comprehensive patient support programs to enhance treatment accessibility and adherence.
equipe executiva do Dermata Therapeutics
- Gerald T. ProehlFounder, President, CEO & Chairman
- David F. HaleCo-Founder & Lead Independent Director
- Kyri K. Van HooseSenior VP & CFO
- Christopher J. NardoSenior VP & Chief Development Officer
- Sean ProehlAssociate General Counsel
- Kyra PeckaitisVice President of Marketing
- Maria Bedoya Toro MuneraSenior Vice President of Regulatory Affairs & Quality Assurance
Principais indicadores financeiros
Resultados divulgados pela Dermata Therapeutics, em USD.
- Cap. de mercado
- 3,7 mi
- Receita (TTM)
- 0
- P/L
- —
- LPA (diluído, TTM)
- -4.4
- Dividend yield
- —
- Margem de lucro
- 0.0%
| Fim do ano fiscal | Receita | Resultado operacional | Lucro líquido |
|---|---|---|---|
| 0 | -7,8 mi | -7,6 mi | |
| 0 | -12,5 mi | -12,3 mi | |
| 0 | -8 mi | -7,8 mi | |
| 0 | -9,7 mi | -9,6 mi |